Eric Lefkofsky is an American entrepreneur whose business savvy is undeniable. Lefkosky is famous for being the co-founder and Chairman of Groupon. However, he has also been involved with companies such as InnerWorkings (a global provider of managed print and promotional solutions), Echo Global Logistics (a technology-enabled transportation and logistics outsourcing firm), Mediaocean (a leading provider of integrated media procurement technology), Lightbank (a venture fund investing in disruptive technology businesses), and Uptake Technologies (a leading predictive analytics platform for the world’s largest industries). Follow him in his linkedin.com page.
In addition to being known for his business success, Lefkofsky is known for his philanthropy. He serves as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago. Eric Lefkofsky is also Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company.
Recently, Eric Lefkofsky has combined his entrepreneurial spirit and his concern for his fellow man by becoming the founder and CEO of a business called Tempus. The company’s goal is to promote a better understanding of cancer, so the disease can be treated more effectively.
Tempus is a technology company whose goal is to build the world’s largest library of molecular and clinical data for physicians to reference while they treat a patient. The company performs genomic and transcriptomic sequencing and analysis. It then uses bioinformatics and a machine learning platform to help physicians analyze these data sets and identify patterns/potentially actionable treatments. It is the hope that data from other cancer patients will enable physicians to provide treatments that are unique to each of their current patients. Click on chicagobusiness.com for more additional details.
So far, Tempus has formed partnerships with Northwestern University’s Robert H. Lurie Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, University of Pennsylvania’s Abramson Cancer Center, and Mayo Clinic’s Center for Individualized Medicine. Fortunately, Tempus (and its data bank) are continuing to grow.
Check this link http://lefkofskyfoundation.com/about-eric-lefkofsky/